Eosinophilic Gastroenteritis
18
3
4
11
Key Insights
Highlights
Success Rate
79% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 49/100
16.7%
3 terminated out of 18 trials
78.6%
-7.9% vs benchmark
22%
4 trials in Phase 3/4
64%
7 of 11 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 11 completed trials
Clinical Trials (18)
Eosinophilic Gastrointestinal Disorders Registry
Dupilumab in Eosinophilic Gastritis
A Study to Evaluate the Efficacy and Safety of CC-93538 in Adult and Adolescent Japanese Participants With Eosinophilic Gastroenteritis
Examining the Effect of Ondansetron on Bowel Prep Success
A Study to Learn How Well Dupilumab Works in Adult and Adolescent Participants With Eosinophilic Gastritis With or Without Eosinophilic Duodenitis and the Side Effects it May Have
OMEGA: Outcome Measures in Eosinophilic Gastrointestinal Disorders Across the Ages
Efficacy and Safety of Benralizumab in Patients With Eosinophilic Gastritis and/or Gastroenteritis (The HUDSON GI Study)
Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
An Extension Study of AK002 in Patients With Eosinophilic Gastritis and/or Eosinophilic Duodenitis
A Study of AK002 in Patients With Eosinophilic Gastritis and/or Eosinophilic Gastroenteritis
A Study of Lirentelimab (AK002) in Patients With Active Eosinophilic Duodenitis
Characteristics of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort
Effect of Elemental Diet on Adult Patients With Eosinophilic Gastroenteritis
Anti-Interleukin-5 (IL-5) Study for Hypereosinophilic Syndrome
Sirolimus for Eosinophil-Associated Gastrointestinal Disorders
Immunopathogenesis of Food Allergy and Eosinophilic Gastrointestinal Disorders
Data Bank for Eosinophilic Disorders
Montelukast in the Treatment of Duodenal Eosinophilia